3//SEC Filing
Noble Medical Technologies, Inc. 3
Accession 0001144204-11-040053
CIK 0001433593operating
Filed
Jul 10, 8:00 PM ET
Accepted
Jul 11, 7:15 PM ET
Size
29.3 KB
Accession
0001144204-11-040053
Insider Transaction Report
Form 3
Trinad Management, LLC
10% OwnerOther
Holdings
- 3,978,000(indirect: See Footnote)
Common Stock
Warrant
Exercise: $0.10From: 2011-03-21Exp: 2021-03-20→ Common Stock (2,000,000 underlying)- 3,978,600
Common Stock
Trinad Capital Master Fund Ltd.
10% Owner
Holdings
Warrant
Exercise: $0.10From: 2011-03-21Exp: 2021-03-20→ Common Stock (2,000,000 underlying)- 3,978,600
Common Stock
- 3,978,000(indirect: See Footnote)
Common Stock
Footnotes (3)
- [F1]The Shares of Common Stock are directly beneficially owned by Trinad Capital Master Fund, Ltd.
- [F2]Trinad Management, LLC is the investment manager of Trinad Capital Master Fund and exercises voting and disposition power over the shares of Trinad Capital Master Fund. Robert Ellin is one of the managing members of Trinad Management and as such may be deemed to control Trinad Capital Master Fund and Trinad Management. Accordingly, securities owned by these entities may be regarded as being beneficially owned by Mr. Ellin. Mr. Ellin disclaims beneficial ownership in the shares held by Trinad Management and Trinad Capital Master Fund.
- [F3]The warrant is directly beneficially owned by Trinad Management, LLC.
Issuer
Noble Medical Technologies, Inc.
CIK 0001433593
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001433593
Filing Metadata
- Form type
- 3
- Filed
- Jul 10, 8:00 PM ET
- Accepted
- Jul 11, 7:15 PM ET
- Size
- 29.3 KB